BioSpace News Archive

Vera Whole Health, a national leader in advanced primary care, today released an eBook to provide employers, insurers, and health systems with fundamental information about this proven care methodology.

Citra Health Solutions announces the launch of Citra Cloud™, a hosting service powered by Med Tech Solutions, providing seamless availability of a comprehensive hosted environment and IT infrastructure for optimal performance of the full EZ-Suite platform, as well as third party integrations.

POXEL S.A. (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced today that it will be featured as a presenting company at the H.C. Wainwright 21st Annual Global Investment Conference.

L.A. Care Health Plan and Blue Shield of California Promise Health Plan announced today that they will invest a combined $146 million as part of a five-year commitment to expand Community Resource Centers across Los Angeles County.

Chubb Workplace Benefits, a Chubb business that partners with benefits brokers, agents and consultants to offer voluntary benefits to the employees of middle-market and large companies in the U.S, announced today its next generation of group critical illness and accident products.

Fourth Annual Fundraiser for Childhood Cancer Research is Kicking Off During Childhood Cancer Awareness Month on Sept. 9

Canopy Health announced today an expansion of its collaboration with Health Net.

CannRx, a company developing proprietary, scientifically based medical and recreational products, today announced that Dr. Shimon Lecht, the Company’s Chief R&D Officer, will present a poster at this year’s MJBizCon INT’L conference in Toronto, Canada

Invitae Corporation (NYSE: NVTA) today announced its intention to offer, subject to market conditions and other factors, $200.0 million aggregate principal amount of convertible senior notes due 2024 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York, NY on Tuesday, September 10 at 12:20 p.m. Eastern Time.